IT1299161B1 - Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph - Google Patents

Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph

Info

Publication number
IT1299161B1
IT1299161B1 IT98RM000238A ITRM980238A IT1299161B1 IT 1299161 B1 IT1299161 B1 IT 1299161B1 IT 98RM000238 A IT98RM000238 A IT 98RM000238A IT RM980238 A ITRM980238 A IT RM980238A IT 1299161 B1 IT1299161 B1 IT 1299161B1
Authority
IT
Italy
Prior art keywords
carnitine
alcanoyl
nadh
nadph
composition including
Prior art date
Application number
IT98RM000238A
Other languages
English (en)
Italian (it)
Inventor
Per Il Credito Sporti Istituto
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of ITRM980238A0 publication Critical patent/ITRM980238A0/it
Priority to IT98RM000238A priority Critical patent/IT1299161B1/it
Priority to CN99805644A priority patent/CN1299283A/zh
Priority to PCT/IT1999/000088 priority patent/WO1999053921A1/fr
Priority to SK1544-2000A priority patent/SK15442000A3/sk
Priority to CA002328331A priority patent/CA2328331A1/fr
Priority to KR1020007011499A priority patent/KR20010042765A/ko
Priority to TR2000/02894T priority patent/TR200002894T2/xx
Priority to HU0101914A priority patent/HUP0101914A3/hu
Priority to EEP200000601A priority patent/EE200000601A/xx
Priority to BR9909712-5A priority patent/BR9909712A/pt
Priority to EP99916039A priority patent/EP1071424A1/fr
Priority to PL99343482A priority patent/PL343482A1/xx
Priority to JP2000544325A priority patent/JP2002512191A/ja
Priority to AU34428/99A priority patent/AU750645B2/en
Priority to IL13901499A priority patent/IL139014A0/xx
Publication of ITRM980238A1 publication Critical patent/ITRM980238A1/it
Application granted granted Critical
Publication of IT1299161B1 publication Critical patent/IT1299161B1/it
Priority to NO20005128A priority patent/NO20005128L/no
Priority to IS5663A priority patent/IS5663A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT98RM000238A 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph IT1299161B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
EEP200000601A EE200000601A (et) 1998-04-17 1999-04-14 L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon
EP99916039A EP1071424A1 (fr) 1998-04-17 1999-04-14 Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph
SK1544-2000A SK15442000A3 (sk) 1998-04-17 1999-04-14 Kompozícia obsahujúca l-karnitín alebo alkanoyl-l-karnitín a nikotínamid adenín dinukleotid a/alebo nikotínamid adenín dinukleotid fosfát
CA002328331A CA2328331A1 (fr) 1998-04-17 1999-04-14 Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph
KR1020007011499A KR20010042765A (ko) 1998-04-17 1999-04-14 Ｌ-카르니틴 또는 알카노일 ｌ-카르니틴 그리고 ｎａｄｈ및/또는 ｎａｄｐｈ가 포함되는 조성물
TR2000/02894T TR200002894T2 (tr) 1998-04-17 1999-04-14 L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon
HU0101914A HUP0101914A3 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
CN99805644A CN1299283A (zh) 1998-04-17 1999-04-14 包含l－肉毒碱或烷酰基l－肉毒碱和nadh和/或nadph的组合物
BR9909712-5A BR9909712A (pt) 1998-04-17 1999-04-14 Composição compreendendo l-carnitina ou um alcanoil-l-carnitina e nadh e/ou madph
PCT/IT1999/000088 WO1999053921A1 (fr) 1998-04-17 1999-04-14 Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph
PL99343482A PL343482A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
JP2000544325A JP2002512191A (ja) 1998-04-17 1999-04-14 Ｌ−カルニチンまたはアルカノイルｌ−カルニチンおよびｎａｄｈおよび／またはｈａｄｐｈを含む組成物。
AU34428/99A AU750645B2 (en) 1998-04-17 1999-04-14 Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
IL13901499A IL139014A0 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
NO20005128A NO20005128L (no) 1998-04-17 2000-10-12 Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH
IS5663A IS5663A (is) 1998-04-17 2000-10-13 Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph

Publications (3)

Publication Number Publication Date
ITRM980238A0 ITRM980238A0 (it) 1998-04-17
ITRM980238A1 ITRM980238A1 (it) 1999-10-17
IT1299161B1 true IT1299161B1 (it) 2000-02-29

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph

Country Status (17)

Country Link
EP (1) EP1071424A1 (fr)
JP (1) JP2002512191A (fr)
KR (1) KR20010042765A (fr)
CN (1) CN1299283A (fr)
AU (1) AU750645B2 (fr)
BR (1) BR9909712A (fr)
CA (1) CA2328331A1 (fr)
EE (1) EE200000601A (fr)
HU (1) HUP0101914A3 (fr)
IL (1) IL139014A0 (fr)
IS (1) IS5663A (fr)
IT (1) IT1299161B1 (fr)
NO (1) NO20005128L (fr)
PL (1) PL343482A1 (fr)
SK (1) SK15442000A3 (fr)
TR (1) TR200002894T2 (fr)
WO (1) WO1999053921A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
MX2009012042A (es) * 2007-05-11 2009-12-01 Sigma Tau Ind Farmaceuti Gel util para el suministro de ingredientes activos cosmeticos.
WO2011022786A1 (fr) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Procédés de diagnostic et de traitement du syndrome de fatigue chronique
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
ES2786774B2 (es) * 2017-12-22 2022-03-04 Bontac Bio Eng Shenzhen Co Ltd Composición para compuesto de coenzima NADH, preparación y aplicación del mismo.
PL3755160T3 (pl) 2018-04-20 2022-02-14 Pacotrade Ag Urządzenie do rozdrabniania głęboko mrożonych środków spożywczych przygotowanych w formie bloku
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CA3115743A1 (fr) * 2018-10-10 2020-04-16 So Ngor Sally LEUNG Composition de produit de sante permettant de compenser un deficit, son procede de preparation et son application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (fr) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
EE200000601A (et) 2002-04-15
IS5663A (is) 2000-10-13
CA2328331A1 (fr) 1999-10-28
KR20010042765A (ko) 2001-05-25
TR200002894T2 (tr) 2001-01-22
WO1999053921A1 (fr) 1999-10-28
NO20005128L (no) 2000-12-18
SK15442000A3 (sk) 2001-06-11
HUP0101914A3 (en) 2002-12-28
BR9909712A (pt) 2000-12-26
NO20005128D0 (no) 2000-10-12
JP2002512191A (ja) 2002-04-23
IL139014A0 (en) 2001-11-25
HUP0101914A2 (hu) 2002-03-28
ITRM980238A1 (it) 1999-10-17
ITRM980238A0 (it) 1998-04-17
PL343482A1 (en) 2001-08-27
AU750645B2 (en) 2002-07-25
CN1299283A (zh) 2001-06-13
AU3442899A (en) 1999-11-08
EP1071424A1 (fr) 2001-01-31

Similar Documents

Publication Publication Date Title
DE69933825D1 (de) Chemisch verstärkte Positivresistzusammensetzung
HUP0104270A3 (en) Herbicidal composition and use thereof
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
DE69933544D1 (de) Polymer und härtbare zusammensetzung
DE69927945D1 (de) Elektromechanisches schütz
AU2052800A (en) Metal and wood bat
DK1112003T3 (da) Ny sammensætning og anvendelse
DE69909919D1 (de) Wasserdispergierbare wasser- und ölabweisende Zusammensetzung
DE69836432D1 (de) Bildcoder und -decoder
NO20006488D0 (no) Sammensetning og anvendelse
DE59906436D1 (de) Sulfid- und oxisulfidpigmente
DE69836248D1 (de) Wasser- und Ölabweisende Zusammensetzung
AU1037900A (en) Magnetic bearing and its use
IT1299161B1 (it) Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
DE69917327D1 (de) 3,3-biarylpiperidin- und 3,3-biarylmorpholinderivate
NO993694L (no) Sylfonylurea- og adjuvansbaserte faste blandinger
DE69822091D1 (de) Photoempfindliches Polymer und dieses enthaltende chemisch verstärkte Resistzusammensetzung
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
EP1090935A4 (fr) Fluorocopolymere et composition a base de celui-ci
DE29900311U1 (de) Achsen- und Kugellageranordnung
DE69926160D1 (de) Tonerzusammensetzung und deren Herstellung
FR2779445B1 (fr) Kit d'encapsidation
PL338379A1 (en) Novel photoinitiators and their application
FI972010A0 (fi) Arrangemang i en borrningsanordning
ITMI980827A1 (it) Composizioni e sostanze ad attivita' dermoproliferativa

Legal Events

Date Code Title Description
0001 Granted